Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

NCT04939857 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Cardiotoxicity

Interventions

DRUG: Trimetazidine

Sponsor

Peking University Third Hospital